Quadrature Capital Ltd Acquires Shares of 53,610 The Cooper Companies, Inc. (NASDAQ:COO)

Quadrature Capital Ltd acquired a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 53,610 shares of the medical device company’s stock, valued at approximately $5,437,000.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in Cooper Companies by 303.0% in the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after buying an additional 17,367,502 shares during the last quarter. Capital World Investors lifted its holdings in shares of Cooper Companies by 301.7% in the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after acquiring an additional 4,246,519 shares during the last quarter. Bessemer Group Inc. lifted its holdings in shares of Cooper Companies by 305.2% in the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after acquiring an additional 1,507,049 shares during the last quarter. Champlain Investment Partners LLC boosted its stake in shares of Cooper Companies by 295.3% during the 1st quarter. Champlain Investment Partners LLC now owns 1,741,120 shares of the medical device company’s stock worth $176,654,000 after purchasing an additional 1,300,620 shares during the period. Finally, Bank of New York Mellon Corp grew its holdings in Cooper Companies by 273.8% during the 1st quarter. Bank of New York Mellon Corp now owns 1,731,194 shares of the medical device company’s stock valued at $175,647,000 after purchasing an additional 1,268,109 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

COO has been the subject of several recent analyst reports. Citigroup boosted their target price on Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price objective on shares of Cooper Companies in a research report on Wednesday, July 3rd. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, May 31st. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their target price for the company from $107.00 to $115.00 in a research note on Tuesday, July 16th. Finally, Robert W. Baird raised their price target on shares of Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $111.78.

Cooper Companies Stock Up 0.6 %

NASDAQ COO traded up $0.53 during trading on Friday, reaching $93.21. 1,063,395 shares of the company’s stock traded hands, compared to its average volume of 1,241,350. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $104.07. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14. The firm has a market cap of $18.56 billion, a price-to-earnings ratio of 54.75, a price-to-earnings-growth ratio of 2.30 and a beta of 0.98. The company’s 50 day simple moving average is $91.31 and its two-hundred day simple moving average is $94.29.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.02. The company had revenue of $942.60 million for the quarter, compared to analyst estimates of $948.07 million. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. Cooper Companies’s revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $0.77 earnings per share. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.